Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.

Rudin CM, Brahmer JR, Juergens RA, Hann CL, Ettinger DS, Sebree R, Smith R, Aftab BT, Huang P, Liu JO.

J Thorac Oncol. 2013 May;8(5):619-23. doi: 10.1097/JTO.0b013e31828c3950.

PMID:
23546045
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Qi WX, Tang LN, He AN, Shen Z, Yao Y.

J Cancer Res Clin Oncol. 2012 May;138(5):745-51. doi: 10.1007/s00432-012-1155-9. Epub 2012 Jan 19. Review.

PMID:
22258853
[PubMed - indexed for MEDLINE]

Supplemental Content

Write to the Help Desk